Inspire Medical Systems, Inc. Standard Product Warranty Accrual, Decrease for Payments
Inspire Medical Systems, Inc. (INSP) reported Standard Product Warranty Accrual, Decrease for Payments of $431.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Product Warranties Disclosures
us-gaap:StandardProductWarrantyAccrualPayments · last filed 2026-02-13
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for the quarter ending 2025-12-31 was $109.00K, a 26.74% increase year-over-year.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for the quarter ending 2025-09-30 was $128.00K, a 38.16% decline year-over-year.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for the quarter ending 2025-06-30 was $105.00K, a 52.27% decline year-over-year.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for the quarter ending 2025-03-31 was $89.00K, a 63.97% decline year-over-year.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for fiscal 2025 was $431.00K, a 43.29% decline from fiscal 2024.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for fiscal 2024 was $760.00K, a 3.83% increase from fiscal 2023.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for fiscal 2023 was $732.00K, a 111.56% increase from fiscal 2022.
- Inspire Medical Systems, Inc. standard product warranty accrual, decrease for payments for fiscal 2022 was $346.00K, a 29.59% increase from fiscal 2021.
| Period end | Standard Product Warranty Accrual, Decrease for Payments 3 month | Standard Product Warranty Accrual, Decrease for Payments 6 month | Standard Product Warranty Accrual, Decrease for Payments 9 month | Standard Product Warranty Accrual, Decrease for Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $237.00K derived: sum of 2 quarters · filed 2026-02-13 | $342.00K derived: sum of 3 quarters · filed 2026-02-13 | $431.00K 10-K · filed 2026-02-13 |
| 2025-09-30 | $128.00K 10-Q · filed 2025-11-03 | $233.00K derived: sum of 2 quarters · filed 2025-11-03 | $322.00K 10-Q · filed 2025-11-03 | $408.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $105.00K 10-Q · filed 2025-08-04 | $194.00K 10-Q · filed 2025-08-04 | $280.00K derived: sum of 3 quarters · filed 2026-02-13 | $487.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $89.00K 10-Q · filed 2025-05-05 | $175.00K derived: sum of 2 quarters · filed 2026-02-13 | $382.00K derived: sum of 3 quarters · filed 2026-02-13 | $602.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $293.00K derived: sum of 2 quarters · filed 2026-02-13 | $513.00K derived: sum of 3 quarters · filed 2026-02-13 | $760.00K 10-K · filed 2026-02-13 |
| 2024-09-30 | $207.00K 10-Q · filed 2025-11-03 | $427.00K derived: sum of 2 quarters · filed 2025-11-03 | $674.00K 10-Q · filed 2025-11-03 | $834.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $220.00K 10-Q · filed 2025-08-04 | $467.00K 10-Q · filed 2025-08-04 | $627.00K derived: sum of 3 quarters · filed 2026-02-13 | $756.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $247.00K 10-Q · filed 2025-05-05 | $407.00K derived: sum of 2 quarters · filed 2026-02-13 | $536.00K derived: sum of 3 quarters · filed 2026-02-13 | $668.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $289.00K derived: sum of 2 quarters · filed 2026-02-13 | $421.00K derived: sum of 3 quarters · filed 2026-02-13 | $732.00K 10-K · filed 2026-02-13 |
| 2023-09-30 | $129.00K 10-Q · filed 2024-11-04 | $261.00K derived: sum of 2 quarters · filed 2024-11-04 | $572.00K 10-Q · filed 2024-11-04 | $756.00K derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $132.00K 10-Q · filed 2024-08-06 | $443.00K 10-Q · filed 2024-08-06 | $627.00K derived: sum of 3 quarters · filed 2025-02-10 | $688.00K derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $311.00K 10-Q · filed 2024-05-07 | $495.00K derived: sum of 2 quarters · filed 2025-02-10 | $556.00K derived: sum of 3 quarters · filed 2025-02-10 | $616.00K derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $245.00K derived: sum of 2 quarters · filed 2025-02-10 | $305.00K derived: sum of 3 quarters · filed 2025-02-10 | $346.00K 10-K · filed 2025-02-10 |
| 2022-09-30 | $61.00K 10-Q · filed 2023-11-07 | $121.00K derived: sum of 2 quarters · filed 2023-11-07 | $162.00K 10-Q · filed 2023-11-07 | $162.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $60.00K 10-Q · filed 2023-08-01 | $101.00K 10-Q · filed 2023-08-01 | $101.00K derived: sum of 3 quarters · filed 2024-02-09 | $244.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $41.00K 10-Q · filed 2023-05-02 | $41.00K derived: sum of 2 quarters · filed 2024-02-09 | $184.00K derived: sum of 3 quarters · filed 2024-02-09 | $237.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $143.00K derived: sum of 2 quarters · filed 2024-02-09 | $196.00K derived: sum of 3 quarters · filed 2024-02-09 | $267.00K 10-K · filed 2024-02-09 |
| 2021-09-30 | $143.00K 10-Q · filed 2022-11-01 | $196.00K derived: sum of 2 quarters · filed 2022-11-01 | $267.00K 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $53.00K 10-Q · filed 2022-08-02 | $124.00K 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $71.00K 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $93.00K 10-K · filed 2023-02-10 | |||
| 2019-12-31 | $62.00K 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |